【摘 要】
：
Objective To study treatment pattern in patients with type 2 diabetes who were first hospitalized in the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in Qingdao,China.Methods Patients wit
【机 构】
：
Qingdao Endocrine and Diabetes Hospital R & D inf
【出 处】
：
中华医学会糖尿病学分会第十八次全国学术会议
论文部分内容阅读
Objective To study treatment pattern in patients with type 2 diabetes who were first hospitalized in the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in Qingdao,China.Methods Patients with type 2 diabetes(n=13 261,of which 6 696 were men)who were first admitted to the hospital between 2006 and 2012 were included in the cuRRent study.
其他文献
目的 采用靶向LC-MS/MS(液质联用)方法定量检测血清氨基酸(代谢组学方法证实的2型糖尿病较强预测因子)在2型糖尿病患者中的分布特点,并探讨与胰岛素抵抗的相关性及与血糖、血脂等多项代谢指标的关系.
目的 本研究试图在中国2型糖尿患者群中再现ATM基因rs11212617基因多态性与二甲双胍疗效的相关性.方法 收集近1年在汕头大学医学院第二附属医院和汕头市中心医院内分泌科门诊的初诊2型糖尿病患者(符合1999年WHO糖尿病诊断标准,年龄30～65周岁,空腹血糖7.0～ 15.0mmol/L,体质指数(BMI)18.5 ～ 30.0 kg/m2)93例.
目的 研究P38MAPK-FN信号转导通路在糖尿病肾病中发挥的作用以及津力达颗粒对链脲佐菌素(STZ)诱导的糖尿病大鼠肾脏的保护作用.,方法 大鼠适应性喂养7d,腹腔注射STZ 65 mg/kg,对照组腹腔注射等剂量柠檬酸缓冲液作为对照.大鼠分别在实验前和杀死前称重,代谢笼收集24 h尿液.
目的 复制2型糖尿病(T2DM)大鼠模型,观察糖尿病大鼠肾脏RhoA表达水平、形态学改变及辛伐他汀治疗的影响,探讨RhoA在2型糖尿病肾脏病变中的作用和辛伐他汀肾脏保护作用及机制.方法 从50只SD大鼠中随机抽取10只作为正常对照组(A组),其余作为实验组.取血测定空腹血糖(FBG)、空腹胰岛素(FINS)、胰岛素敏感指数(ISI)、血肌酐(Scr)与血脂、尿白蛋白与尿肌酐(Ucr),并计算内生肌
Objective Pioglitazone may increase the incidence of bladder cancer.The cuRRent meta-analysis summarized researches from incomplete,small number and single type of literature.The purpose of this study
Objective To explore the effects of serum triglyceride on islet b cell function and insulin resistance of patients with newly diagnosed gestational diabetes mellitus(GDM).Methods Total of 439 newly di
Objective To assess the changes of mean platelet volume(MPV)in type 2 diabetes mellitus(T2DM)(glycated hemoglobin A1c(HbA1c)＞7％)with treatment intervention,compare Metabolism index and MPV before and
Ohjeetives To investigate the effects of glibenclamide and repaglinide in newly diagnosed patients with type 2 diabetes mellitu(T2DM).Methods Total of 120 patients newly diagnosed with type 2 diabetes
Objective To systematically review the effects of glucagonlike peptide-1 receptor agonists(GLP-1 RAs)on two common digestive system adverse events(DSAE: dyspepsia and anorexia)in patients with type 2
Objeetives In the case of stable blood sugar control may metformin and insulin affect the glucagon-like peptide 1(GLP-1)and glucagon? We cured the newly diagnosed type 2 diabetes mellitus(T2DM)patient